Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Authors:
Open Access
- 27 April 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, rare progressive lung disease, characterized by lung scarring and the irreversible loss of lung function. Two anti-fibrotic drugs, nintedanib and pirfenidone, have been demonstrated to slow down disease progression, although IPF mortality remains a challenge and the patients die after a few years from diagnosis. Rare pathogenic variants in genes that are involved in the surfactant metabolism and telomere maintenance, among others, have a high penetrance and tend to co-segregate with the disease in families. Common recurrent variants in the population with modest effect sizes have been also associated with the disease risk and progression. Genome-wide association studies (GWAS) support at least 23 genetic risk loci, linking the disease pathogenesis with unexpected molecular pathways including cellular adhesion and signaling, wound healing, barrier function, airway clearance, and innate immunity and host defense, besides the surfactant metabolism and telomere biology. As the cost of high-throughput genomic technologies continuously decreases and new technologies and approaches arise, their widespread use by clinicians and researchers is efficiently contributing to a better understanding of the pathogenesis of progressive pulmonary fibrosis. Here we provide an overview of the genetic factors known to be involved in IPF pathogenesis and discuss how they will continue to further advance in this field. We also discuss how genomic technologies could help to further improve IPF diagnosis and prognosis as well as for assessing genetic risk in unaffected relatives. The development and validation of evidence-based guidelines for genetic-based screening of IPF will allow redefining and classifying this disease relying on molecular characteristics and contribute to the implementation of precision medicine approaches.Keywords
This publication has 172 references indexed in Scilit:
- The telomere syndromesNature Reviews Genetics, 2012
- IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression studyImmunogenetics, 2012
- Telomere length measurement—Caveats and a critical assessment of the available technologies and toolsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Endoplasmic reticulum stress enhances fibrotic remodeling in the lungsProceedings of the National Academy of Sciences, 2011
- A CommonMUC5BPromoter Polymorphism and Pulmonary FibrosisNew England Journal of Medicine, 2011
- Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with AgingThe American Journal of Human Genetics, 2009
- Dyskeratosis CongenitaHematology/Oncology Clinics of North America, 2009
- Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung CancerThe American Journal of Human Genetics, 2009
- Short telomeres are a risk factor for idiopathic pulmonary fibrosisProceedings of the National Academy of Sciences, 2008
- Adult-onset pulmonary fibrosis caused by mutations in telomeraseProceedings of the National Academy of Sciences, 2007